Request a copy

Full Text

• Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25 (2002) 593-598
• Radermecker R.P., and Scheen A.J. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab. Res. Rev. 20 (2004) 178-188
• Guilhem I., Leguerrier A.M., Lecordier F., Poirier J.Y., and Maugendre D. Technical risks with subcutaneous insulin infusion. Diabetes Metab. 32 (2006) 279-284
• Mecklenburg R.S., Benson E.A., Benson Jr. J.W., Fredlund P.N., Guinn T., Metz R.J., et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 252 (1984) 3265-3269
• Chantelau E., Lange G., Sonnenberg G.E., and Berger M. Acute cutaneous complications and catheter needle colonization during insulin-pump treatment. Diabetes Care 10 (1987) 478-482
• Radermecker R.P., Legrand D.A., and Scheen A.J. Continuous subcutaneous insulin therapy in type 1 diabetic patients: retrospective study of about 500 patient-years. Diabetologia 48 Suppl 1 (2005) A328 (abstract)
• Tanner M.H., and Liljenquist J.E. Toxic shock syndrome from Staphylococcus aureus infection at insulin pump infusion sites. Report of two cases. JAMA 259 (1998) 394-395
• Teutsch S.M., Herman W.H., Dwyer D.M., and Lane J.M. Mortality among diabetic patient using continuous subcutaneous insulin-infusion pumps. N. Engl. J. Med. 310 (1984) 361-368
• Castillo M.J., Scheen A., and Lefèbvre P.J. Treatment with insulin infusion pumps and ketoacidotic episodes: from physiology to troubleshooting. Diabetes Metab. Rev. 11 (1995) 161-177
• Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 (2005) 751-762
• Lipsky B.A., Pecoraro R.E., Chen M.S., and Koepsell T.D. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10 (1987) 483-486
• Van Faassen I., Razenberg P.P.A., Simoons-Smit A.M., and van der Veen E.A. Carriage of Staphylococcus aureus and inflamed infusion sites with insulin-pump therapy. Diabetes Care 12 (1989) 153-155
• Finkelstein R., Sobel J.D., Nagler A., and Merzbach D. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J. Med. 15 (1984) 193-211
• Fowler Jr. V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005) 3012-3021